| 16013/34347 | US=22 / Urologia Jonasch E, Walker CL. EGFR and HER2: relevance in renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 287-303. ISBN 978-1-58829-737-2. CARCINOMA DE CELULAS RENAIS; ERBB; TERAPIA-ALVO; RESISTENCIA; SINALIZACAO |
| 16014/34347 | US=22 / Urologia Garcia JA, Varizi SJA, Ganapathi R. Proteasome-NFkB signaling pathway: relevance in RCC. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 305-20. ISBN 978-1-58829-737-2. SISTEMA UBIQUITINA-PROTEASSOMA; VIA DE PROTEASSOMA NA RCC; INIBICAO DO PROTEASSOMA |
| 16015/34347 | US=22 / Urologia Peruzzi B, Lattouf JB, Bottaro DP. The role of hepatocyte growth factor pathway signaling in renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 321-34. ISBN 978-1-58829-737-2. FATOR DE CRESCIMENTO HEPATOCITO; C-MET; CARCINOMA DE CELULAS RENAIS; MECANISMOS ONCOGENICOS; DESENVOLVIMENTO DROGA CONTRA O CANCER |
| 16016/34347 | US=22 / Urologia Mizutani Y, kawauchi A, Bonavida B, Miki T. Smac/DIABLO: a proapoptotic molecular target in renal cell cancer. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 335-46. ISBN 978-1-58829-737-2. CARCINOMA DE CELULAS RENAIS; SMAC / DIABLO; PROGNOSTICO; APOPTOSE; CISPLATINA; XIAP; RCC; TRAIL |
| 16017/34347 | US=22 / Urologia Kawabe M, Herrem CJ, Finke JH, Storkus WJ. EphA2: a novel target in renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 347-66. ISBN 978-1-58829-737-2. RTK; CD8+ T LINFOCITOS; QUINASE DE TIROSINA RECEPTORA; PROTEASSOMA; TERAPIA COMBINATORIA; COMPLEXO PRINCIPAL DE HISTOCOMPATIBILIDADE |
| 16018/34347 | US=22 / Urologia Inman BA, Frigola X, Dong H, Yang JC, Kwon ED. Restoring host antitumoral immunity: how coregulatory molecules are changing the approach to the management of renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 367-403. ISBN 978-1-58829-737-2. COESTIMULACAO; INIBICAO; IMUNOLOGIA DE TUMORES; IMMUNOEDITING; IMUNOTERAPIA; LINFOCITOS T; CARCINOMA DE CELULAS RENAIS |
| 16019/34347 | US=22 / Urologia Shaheen PE, Bukowski RM, Finke JH. The role of gangliosides in renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 405-23. ISBN 978-1-58829-737-2. GANGLIOSIDEOS NA RCC; GLICOESFINGOLIPIDOS; GANGLIOSIDOS E VEGF; GANGLIOSIDEOS COMO ALVOS TERAPEUTICOS |
| 16020/34347 | US=22 / Urologia Parton M, Das T, Sa G, Finke J, Eisen T, Tannenbaum C. Tumour necrosis factor - misnomer and therapeutic target. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 425-48. ISBN 978-1-58829-737-2. FATOR DE NECROSE TUMORAL; CITOCINA; IMUNOMODULACAO; ANGIOGENESE; FATOR DE CRESCIMENTO |
| 16021/34347 | US=22 / Urologia Nogueira M, Kim HL. Molecular markers for predicting prognosis of renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 449-71. ISBN 978-1-58829-737-2. CARCINOMA DE CELULAS RENAIS; MARCADORES MOLECULARES; PROGNOSTICO |
| 16022/34347 | US=22 / Urologia Kadar AK, Wood CG. Adjuvant therapy for renal cell carcinoma: targeted approaches. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 473-95. ISBN 978-1-58829-737-2. TERAPIA ADJUVANTE; CARCINOMA DE CELULAS RENAIS; DOENCA LOCALMENTE AVANCADA |
| 16023/34347 | US=9 / Quimioterapia Cross HS, Nittke T. Selected vitamins: vitamina D. In: Knasmüller S, DeMarini DM, Johnson I, Gerhäuser C. Chemoprevention of cancer and DNA damage by dietary factors. Weinheim: Wiley-VCH, 2009. p. 393-402. ISBN 978-3-527-32058-5. PREVENCAO DO CANCER; VITAMINA D; SINTESE DA VITAMINA D; PROPRIEDADES FISICO-QUIMICAS; BIODISPONIBILIDADE; METABOLISMO; MECANISMOS PROTETORES; PROCESSAMENTO DE ALIMENTOS; NUTRICAO |
| 16024/34347 | US=9 / Quimioterapia Lee HJ, Suh N. Selected vitamins: vitamina E. In: Knasmüller S, DeMarini DM, Johnson I, Gerhäuser C. Chemoprevention of cancer and DNA damage by dietary factors. Weinheim: Wiley-VCH, 2009. p. 402-15. ISBN 978-3-527-32058-5. VITAMINA E; PROPRIEDADES FISICO-QUIMICAS; BIODISPONIBILIDADE; METABOLISMO; MECANISMOS PROTETORES; DANO OXIDATIVO AO DNA; PROCESSAMENTO DE ALIMENTOS; PREVENCAO DO CANCER |
| 16025/34347 | US=22 / Cirurgia Colon GA. Office pratice of plastic surgery. In: Aston SJ, Steinbrech DS, Walden JL. Aesthetic plastic surgery. Philadelphia: Elsevier Saunders, 2009. p. 3-13. ISBN 978-0-7020-3168-7. |
| 16026/34347 | US=22 / Cirurgia Lambros V. Clinical photography for the aesthetic patient. In: Aston SJ, Steinbrech DS, Walden JL. Aesthetic plastic surgery. Philadelphia: Elsevier Saunders, 2009. p. 15-24. ISBN 978-0-7020-3168-7. ESTETICA; CIRURGIA PLASTICA; FOTOGRAFIA CLINICA; FOTOGRAFIA DIGITAL |
| 16027/34347 | US=22 / Cirurgia Zelman M, Ceradini DJ. Anesthesia in aesthetic surgery. In: Aston SJ, Steinbrech DS, Walden JL. Aesthetic plastic surgery. Philadelphia: Elsevier Saunders, 2009. p. 27-35. ISBN 978-0-7020-3168-7. ESTETICA; CIRURGIA PLASTICA; ANESTESIA; MEDICAMENTOS PRE-OPERATORIOS; ANESTESIA. METODOS |
| 16028/34347 | US=22 / Cirurgia Shafer DM, Opperman S. Postoperative nausea and vomiting. In: Aston SJ, Steinbrech DS, Walden JL. Aesthetic plastic surgery. Philadelphia: Elsevier Saunders, 2009. p. 37-41. ISBN 978-0-7020-3168-7. ESTETICA; CIRURGIA PLASTICA; NAUSEAS; VOMITOS; POS-OPERATORIO; TRATAMENTO PROFILATICO; TRATAMENTO MEDICAMENTOSO |
| 16029/34347 | US=22 / Cirurgia Jewell M. Patient safety in aesthetic surgery. In: Aston SJ, Steinbrech DS, Walden JL. Aesthetic plastic surgery. Philadelphia: Elsevier Saunders, 2009. p. 43-9. ISBN 978-0-7020-3168-7. |
| 16030/34347 | US=22 / Cirurgia Mendelson B. Facelift anatomy, SMAS, retaining ligaments and facial spaces. In: Aston SJ, Steinbrech DS, Walden JL. Aesthetic plastic surgery. Philadelphia: Elsevier Saunders, 2009. p. 53-71. ISBN 978-0-7020-3168-7. ESTETICA; CIRURGIA PLASTICA; LIFTING DE FACE; FACELIFT; SISTEMA MUSCULO APONEUROTICO SUPERFICIAL DA FACE (SMAS); FACE. ANATOMIA |
| 16031/34347 | US=22 / Cirurgia Aston SJ, Walden J. Facelift with SMAS technique and FAME. In: Aston SJ, Steinbrech DS, Walden JL. Aesthetic plastic surgery. Philadelphia: Elsevier Saunders, 2009. p. 73-85. ISBN 978-0-7020-3168-7. ESTETICA; CIRURGIA PLASTICA; LIFTING DE FACE; FACELIFT; SISTEMA MUSCULO APONEUROTICO SUPERFICIAL DA FACE (SMAS); TECIDOS DA CAMADA PROFUNDA. CIRURGIA; FACE; PESCOCO |
| 16032/34347 | US=22 / Cirurgia Stuzin JM. The SMAS facelift - restoring facial shape in facelifting. In: Aston SJ, Steinbrech DS, Walden JL. Aesthetic plastic surgery. Philadelphia: Elsevier Saunders, 2009. p. 87-99. ISBN 978-0-7020-3168-7. ESTETICA; CIRURGIA PLASTICA; LIFTING DE FACE; FACELIFT; SISTEMA MUSCULO APONEUROTICO SUPERFICIAL DA FACE (SMAS); RESTAURACAO FACIAL |